… We wanted to know if inhaled corticosteroids are an effective and helpful treatment option
for COVID‐19 in any setting (for example, home or hospital) and whether they cause unwanted …

… studies indicates that the inhaled corticosteroids (ICS) routinely … , therefore, may be a
promising treatment for COVID-19. This … studies investigating inhaled corticosteroid treatment for …

… systems activated GR may directly interact with NF-κB and AP-1 to inhibit their activity,
but this does not appear to occur in asthmatic patients treated with inhaled corticosteroids [14]. …

… patients treated with high doses of inhaled corticosteroids for long periods. Although this
may well be an acceptable hazard for the minority of patients with severe asthma, the majority …

… Chronic treatment with inhaled corticosteroids reduces responsiveness to histamine,
cholinergic agonists, allergen (early and late responses), exercise, fog, cold air, bradykinin, …

… suggests that the use of inhaled corticosteroids (ICS) in patients … not given inhaled
corticosteroids, a recognised risk factor for … Clinical evidence does not support corticosteroid …

… of an ideal inhaled corticosteroid for use in the treatment of asthma, review what has been
learned during the past 10 years about the safety of inhaled corticosteroids, and consider …

… Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with ICSs. …

The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs)
critically influence the profile of each of them, but also the significant differences in …

In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids (ICSs)
in combination with long acting beta-2-agonists (LABA) or LABA/long-acting muscarinic …